GLEPID

This brand name is authorized in Nigeria.

Active ingredients

The drug GLEPID contains one active pharmaceutical ingredient (API):

1	Glimepiride UNII 6KY687524K - GLIMEPIRIDE
	Glimepiride is an orally active hypoglycaemic substance belonging to the sulphonylurea group. It may be used in non-insulin dependent (type 2) diabetes mellitus. Glimepiride acts mainly by stimulating insulin release from pancreatic beta cells.
	Read more about Glimepiride

Packages

This drug has been approved in Nigeria as follows:

Identifier	Form	Presentation	Description	Approval
B4-6886	Tablet	GLEPID -2 TABLET TAB 2 mg 3x10	30 RNW-PP-250722 GLEPID -2 TABLET GLIMEPIRIDE USP 2MG GLIMEPIRIDE 2MG, EXCIPIENTS QS B4-6886 Drugs ALIMENTARY TRACT AND METABOLISM Imported Products 310 POM 1 3/2/2022 SEAL HEALTHCARE LIMITED, 2, ASIMOLOWE STREET, OFF 5TH AVENUE, ABESAN ESTATE, LAGOS 80204011 femoade4real@yahoo.com FINECURE PHARMACEUTICAL LTD, VILLAGE SHIMLA PISTAUR, MALSA ROAD, KICHHA, UDHAMSINGH NAGAR, UTTARAKHAND-263148,INDIA, India	28/03/2023

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
A10BB12	Glimepiride	A Alimentary tract and metabolism → A10 Drugs used in diabetes → A10B Blood glucose lowering drugs, excl. insulins → A10BB Sulfonamides, urea derivatives
Discover more medicines within A10BB12

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
NG	Registered Drug Product Database	B4-6886